financetom
Business
financetom
/
Business
/
Gap's Fiscal Q2 Earnings, Net Sales Advance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gap's Fiscal Q2 Earnings, Net Sales Advance
Aug 29, 2024 8:16 AM

09:59 AM EDT, 08/29/2024 (MT Newswires) -- Gap (GAP) reported fiscal Q2 earnings Thursday of $0.54 per diluted share, up from $0.32 a year earlier.

Analysts polled by Capital IQ expected $0.41.

Net sales for the quarter ended Aug. 3 were $3.72 billion, up from $3.55 billion a year earlier.

Analysts surveyed by Capital IQ expected $3.63 billion.

The company said it expects Q3 net sales to be "up slightly."

For fiscal 2024, the company reaffirmed its net sales outlook of "up slightly on a 52-week basis."

Price: 22.35, Change: -0.08, Percent Change: -0.36

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trubar Q3 Revenue Jumps 88%
Trubar Q3 Revenue Jumps 88%
Nov 24, 2025
08:13 AM EST, 11/24/2025 (MT Newswires) -- Trubar ( TRBRF ) said Monday that third-quarter net revenue and adjusted EBITDA both advanced. The company, which manufactures plant-based protein products, said net revenue jumped 88% to US$21.6 million. Adjusted EBITDA rose to $1.4 million from the $1 million in the previous corresponding quarter. Trubar ( TRBRF ) reaffirmed its full year...
Veeva Systems Expands Partnership With Roche Pharmaceuticals
Veeva Systems Expands Partnership With Roche Pharmaceuticals
Nov 24, 2025
08:12 AM EST, 11/24/2025 (MT Newswires) -- Veeva Systems ( VEEV ) said Monday that Roche Pharmaceuticals has extended its partnership with the company by integrating Veeva Vault CRM, a deep application for life sciences. Financial terms of the expanded partnership were not disclosed. The Vault CRM platform includes Veeva AI, which features industry-specific AI agents, including Free Text Agent,...
Arrowhead Pharmaceuticals to Receive $200 Million Payment From Sarepta Therapeutics for Meeting ARO-DM1 Milestone
Arrowhead Pharmaceuticals to Receive $200 Million Payment From Sarepta Therapeutics for Meeting ARO-DM1 Milestone
Nov 24, 2025
08:13 AM EST, 11/24/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Monday that it has earned a $200 million milestone payment from Sarepta Therapeutics ( SRPT ) for meeting a second development milestone event in a phase 1/2 clinical study of ARO-DM1 to treat type 1 myotonic dystrophy. Under the terms of the license and collaboration deal between...
X-energy raises $700 million to expand nuclear reactor projects in US
X-energy raises $700 million to expand nuclear reactor projects in US
Nov 24, 2025
Nov 24 (Reuters) - Nuclear reactor developer X-energy said on Monday it had closed a $700 million financing round led by trading company Jane Street to help expand its supply chain and commercial pipeline. WHY IT'S IMPORTANT The U.S. nuclear industry is undergoing a renaissance after years of stagnation, primarily driven by surging power demand from the so-called hyperscalers that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved